CardieX Limited (CDX.AX)
AUD 0.06
(-3.33%)
AUD 0.06
(-3.33%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.63 Million AUD | 69.82% |
| 2023 | -15.35 Million AUD | -21.25% |
| 2022 | -12.66 Million AUD | -160.45% |
| 2021 | -4.86 Million AUD | -32.54% |
| 2020 | -3.66 Million AUD | -15.07% |
| 2019 | -3.18 Million AUD | -4.79% |
| 2018 | -3.04 Million AUD | 32.8% |
| 2017 | -4.52 Million AUD | 17.65% |
| 2016 | -5.49 Million AUD | -84.09% |
| 2015 | -2.98 Million AUD | 6.73% |
| 2014 | -3.2 Million AUD | -484.95% |
| 2013 | 831.48 Thousand AUD | 129.24% |
| 2012 | -2.84 Million AUD | -6.36% |
| 2011 | -2.67 Million AUD | -45.93% |
| 2010 | -1.83 Million AUD | 36.29% |
| 2009 | -2.87 Million AUD | 35.86% |
| 2008 | -4.48 Million AUD | 30.37% |
| 2007 | -6.43 Million AUD | -22.12% |
| 2006 | -5.27 Million AUD | -55.85% |
| 2005 | -3.38 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -3.19 Million AUD | -477.28% |
| 2024 Q4 | -3.19 Million AUD | 0.0% |
| 2024 Q2 | 846.9 Thousand AUD | -3.58% |
| 2024 FY | -6.72 Million AUD | 56.21% |
| 2024 Q1 | 878.3 Thousand AUD | 113.24% |
| 2023 FY | -15.35 Million AUD | -21.25% |
| 2023 Q4 | -6.63 Million AUD | -96.77% |
| 2023 Q2 | -9.07 Million AUD | -110.99% |
| 2023 Q1 | -4.3 Million AUD | 38.71% |
| 2023 Q3 | -3.37 Million AUD | 62.85% |
| 2022 FY | -12.66 Million AUD | -160.45% |
| 2022 Q4 | -7.02 Million AUD | -110.85% |
| 2022 Q3 | -3.32 Million AUD | 41.44% |
| 2022 Q2 | -5.68 Million AUD | -111.53% |
| 2022 Q1 | -2.68 Million AUD | 28.66% |
| 2021 Q2 | -1.69 Million AUD | -141.63% |
| 2021 Q1 | -703.32 Thousand AUD | 60.21% |
| 2021 Q4 | -3.76 Million AUD | -114.23% |
| 2021 Q3 | -1.75 Million AUD | -3.5% |
| 2021 FY | -4.86 Million AUD | -32.54% |
| 2020 Q2 | -2.38 Million AUD | -131.52% |
| 2020 FY | -3.66 Million AUD | -15.07% |
| 2020 Q4 | -1.76 Million AUD | -120.04% |
| 2020 Q3 | -803.26 Thousand AUD | 66.33% |
| 2020 Q1 | -1.03 Million AUD | 54.05% |
| 2019 Q2 | -692.73 Thousand AUD | 0.0% |
| 2019 Q4 | -2.24 Million AUD | -148.92% |
| 2019 FY | -3.18 Million AUD | -4.79% |
| 2019 Q1 | -692.73 Thousand AUD | 17.73% |
| 2019 Q3 | -900.95 Thousand AUD | -30.06% |
| 2018 Q4 | -841.98 Thousand AUD | 0.0% |
| 2018 Q3 | -841.98 Thousand AUD | -79.78% |
| 2018 FY | -3.04 Million AUD | 32.8% |
| 2018 Q2 | -468.33 Thousand AUD | 0.0% |
| 2018 Q1 | -468.33 Thousand AUD | 10.23% |
| 2017 FY | -4.52 Million AUD | 17.65% |
| 2017 Q2 | -1.46 Million AUD | 0.0% |
| 2017 Q1 | -1.46 Million AUD | -27.99% |
| 2017 Q4 | -521.68 Thousand AUD | 0.0% |
| 2017 Q3 | -521.68 Thousand AUD | 64.32% |
| 2016 Q3 | -1.14 Million AUD | 26.25% |
| 2016 Q4 | -1.14 Million AUD | 0.0% |
| 2016 Q2 | -1.54 Million AUD | 0.0% |
| 2016 Q1 | -1.54 Million AUD | -74.46% |
| 2016 FY | -5.49 Million AUD | -84.09% |
| 2015 FY | -2.98 Million AUD | 6.73% |
| 2015 Q4 | -887.98 Thousand AUD | 0.0% |
| 2015 Q3 | -887.98 Thousand AUD | -58.36% |
| 2015 Q2 | -560.73 Thousand AUD | 0.0% |
| 2015 Q1 | -560.73 Thousand AUD | 27.22% |
| 2014 Q4 | -770.48 Thousand AUD | 0.0% |
| 2014 Q1 | -780.66 Thousand AUD | -415.7% |
| 2014 FY | -3.2 Million AUD | -484.95% |
| 2014 Q2 | -780.66 Thousand AUD | 0.0% |
| 2014 Q3 | -770.48 Thousand AUD | 1.3% |
| 2013 Q3 | -151.37 Thousand AUD | -123.06% |
| 2013 Q2 | 656.35 Thousand AUD | -0.0% |
| 2013 Q4 | -151.37 Thousand AUD | 0.0% |
| 2013 FY | 831.48 Thousand AUD | 129.24% |
| 2013 Q1 | 656.35 Thousand AUD | 198.66% |
| 2012 Q2 | -665.25 Thousand AUD | 0.46% |
| 2012 Q4 | -665.25 Thousand AUD | 0.0% |
| 2012 Q3 | -665.25 Thousand AUD | 0.0% |
| 2012 Q1 | -668.31 Thousand AUD | 0.0% |
| 2012 FY | -2.84 Million AUD | -6.36% |
| 2011 Q1 | -457.95 Thousand AUD | 0.0% |
| 2011 Q4 | -668.31 Thousand AUD | 0.0% |
| 2011 FY | -2.67 Million AUD | -45.93% |
| 2011 Q3 | -668.31 Thousand AUD | 0.0% |
| 2011 Q2 | -668.31 Thousand AUD | -45.93% |
| 2010 Q2 | -457.95 Thousand AUD | 36.29% |
| 2010 Q3 | -457.95 Thousand AUD | 0.0% |
| 2010 Q1 | -718.76 Thousand AUD | 0.0% |
| 2010 FY | -1.83 Million AUD | 36.29% |
| 2010 Q4 | -457.95 Thousand AUD | 0.0% |
| 2009 Q2 | -718.76 Thousand AUD | 35.86% |
| 2009 Q4 | -718.76 Thousand AUD | 0.0% |
| 2009 Q1 | -1.12 Million AUD | 0.0% |
| 2009 Q3 | -718.76 Thousand AUD | 0.0% |
| 2009 FY | -2.87 Million AUD | 35.86% |
| 2008 Q1 | -1.56 Million AUD | 0.0% |
| 2008 Q2 | -1.12 Million AUD | 28.57% |
| 2008 Q3 | -1.12 Million AUD | 0.0% |
| 2008 FY | -4.48 Million AUD | 30.37% |
| 2008 Q4 | -1.12 Million AUD | 0.0% |
| 2007 Q2 | -1.56 Million AUD | -20.91% |
| 2007 Q3 | -1.56 Million AUD | 0.0% |
| 2007 Q4 | -1.56 Million AUD | 0.0% |
| 2007 FY | -6.43 Million AUD | -22.12% |
| 2007 Q1 | -1.29 Million AUD | 0.0% |
| 2006 Q3 | -1.29 Million AUD | 0.0% |
| 2006 Q1 | -838 Thousand AUD | 0.0% |
| 2006 FY | -5.27 Million AUD | -55.85% |
| 2006 Q2 | -1.29 Million AUD | -54.83% |
| 2006 Q4 | -1.29 Million AUD | 0.0% |
| 2005 Q4 | -838 Thousand AUD | 0.0% |
| 2005 Q2 | -838 Thousand AUD | 0.0% |
| 2005 FY | -3.38 Million AUD | 0.0% |
| 2005 Q3 | -838 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 83.431% |
| Adherium Limited | -11.98 Million AUD | 61.338% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 52.658% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -6.242% |
| Anteris Technologies Ltd | -66.63 Million AUD | 93.046% |
| Control Bionics Limited | -5.92 Million AUD | 21.85% |
| Compumedics Limited | -269 Thousand AUD | -1622.57% |
| Cochlear Limited | 521.5 Million AUD | 100.889% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 3.744% |
| Cyclopharm Limited | -9.22 Million AUD | 49.768% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -187.022% |
| Nova Eye Medical Limited | -3.79 Million AUD | -22.036% |
| HeraMED Limited | -6.42 Million AUD | 27.913% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 73.635% |
| ImpediMed Limited | -19.03 Million AUD | 75.658% |
| InhaleRx Limited | -1.38 Million AUD | -234.205% |
| LBT Innovations Limited | -4.74 Million AUD | 2.242% |
| Micro-X Limited | -13.02 Million AUD | 64.43% |
| Neurotech International Limited | -5.58 Million AUD | 17.03% |
| OncoSil Medical Limited | -11.98 Million AUD | 61.335% |
| PolyNovo Limited | 1.16 Million AUD | 498.428% |
| Respiri Limited | -7 Million AUD | 33.806% |
| SomnoMed Limited | -3.84 Million AUD | -20.629% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 72.22% |
| Uscom Limited | -2.4 Million AUD | -92.722% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 20.847% |